Core Viewpoint - Kanghua Biotech plans to acquire 100% equity of Nameixin Biotech to enhance its mRNA technology platform and accelerate vaccine development efficiency [1] Group 1: Acquisition Details - The company intends to subscribe to the new registered capital of Nameixin and acquire existing shares from current shareholders [1] - Upon completion of the transaction, Kanghua Biotech will hold 100% equity in Nameixin [1] Group 2: Strategic Implications - The acquisition will improve the company's biopharmaceutical strategic layout and accelerate the construction of advanced technology platforms [1] - The transaction is expected to enhance core competitiveness and leverage synergies in research, clinical, production, and commercialization between Kanghua Biotech and Nameixin [1] - It will expedite the industrialization process of in-development products and optimize resource allocation efficiency [1]

Core Viewpoint - Tianzhihang (688277) is expected to report a net profit loss of between 165 million to 198 million yuan for 2025, indicating an increase in losses compared to the previous year, with a projected increase of 43.87 million to 76.87 million yuan, representing a year-on-year loss expansion of 36.22% to 63.46% [1] Group 1 - The industry market environment is recovering, leading to significant growth in product sales and technical service revenue [1] - The increase in net profit loss compared to the previous year is primarily due to a substantial decrease in investment income [1] - The implementation of a restricted stock incentive plan has resulted in a significant increase in share-based payment expenses compared to the previous year [1] Group 2 - The reversal of previously recognized losses has led to an increase in deferred income tax expenses, contributing to the growth in income tax expenses compared to the previous year [1] - The combined impact of these factors has resulted in an approximate increase of 89 million yuan in the expanded net profit loss [1]

相关较大金额的赔付事项对互助保险社产生哪些影响？针对渔业相关风险，保险保障机制是如何转移的？ 单季赔付"风暴"袭来 渔业，看似传统，实际上与煤矿、危险化学品等行业一样属于高危行业。一旦发生安全事故，会造成重大损失。 即将成立满两年的全国性相互保险组织中国渔业互助保险社披露了2025年的最新业绩。1月28日，北京商报记者通过该公司第四季度偿付能力报告了解到， 该公司全年累计实现保险业务收入3.47亿元，净利润0.07亿元。透过四季度业绩数据来看，2025年第四季度该组织出现净亏损578.31万元。需要关注的是， 从重大赔付事项来看，2025年第四季度该组织再保后赔付金额（含未决估损）前五位的事项，合计赔付金额超1500万元。 需聚焦专业化、创新与成本控制 中国渔业互助保险社成立于2023年2月15日，是一家全国性相互保险组织，注册地在北京。据了解，该组织的主要发起会员为中国渔业互保协会和7家省 （市）渔业互保协会，初始运营资金为5亿元。 彼时获批筹建之际，在业内人士看来，渔业领域迎来专属相互保险组织，这不仅将补齐行业短板，也有望拓展渔业保险产品种类和范围，为渔民带来更多物 美价廉的保险保障。 进一步而言，这家组 ...

Core Viewpoint - Han Yu Pharmaceutical (300199) expects a significant increase in net profit for 2025, projecting a net profit of 40 million to 50 million yuan, representing a year-on-year growth of 123.03% to 128.79%, indicating a turnaround from losses [1] Group 1: Financial Performance - The company anticipates a turnaround to profitability in 2025, with net profit expected to be between 40 million and 50 million yuan [1] - This projected profit growth marks a substantial improvement compared to the previous year, with an increase of over 123% [1] Group 2: Business Drivers - The primary drivers for this expected growth include a significant increase in the scale of GLP-1 formulations and raw material business [1] - The advancement of the CRDMO (Contract Research, Development, and Manufacturing Organization) business is also contributing to the positive outlook [1] - The company is increasing its investment in research and development, particularly in innovative drug HY3003, to enhance the competitiveness of its core products [1]

AI算力从云端向边缘侧加速渗透，边缘计算赛道迎来确定性爆发。 机构统计显示，全球AI推理芯片市场规模已突破6000亿元，边缘AI芯片成为半导体行业中增速迅猛的细分赛道，据世界半导体市场统计（WSTS）及美国半 导体行业协会（SIA）资料，行业发展重心正从模型训练逐步转向实际场景落地，边缘侧的市场需求迎来快速扩容。 1月28日，边缘AI芯片企业爱芯元智的港股IPO及境内股份全流通事项获证监会备案通过，这家深耕边缘AI赛道的企业正式进入上市倒计时，资本市场有望 迎来"边缘AI芯片第一股"。 爱芯元智招股书显示，公司凭借自研的混合精度NPU及全球首款实现规模商用的AI-ISP技术完成多场景落地，技术实力与商业化能力均通过市场验证，成为 边缘AI赛道具备成熟发展能力的头部玩家。 01． 呼之欲出的第一股 市场对这只潜在"边缘AI芯片第一股"的期待并非无源之水，其中既有对赛道前景的看好，也包含对企业亮眼增长的预期。 北京社科院副研究员王鹏对北京商报记者表示，国内边缘计算领域正迎来场景落地、国产替代等多项红利，具备技术落地和商业化规模的企业，自然成为资 本市场关注的标的。 从招股书披露的历史财务数据来看，2022—202 ...

北京商报讯(记者郭秀娟王悦彤)1月28日，北京商报记者获悉，近日恒顺醋业（600305）推出了一款"香 醋可乐"，该产品特别添加恒顺六年陈香醋，气泡充足酸甜解腻，外瓶沿袭"镇江香醋"复古设计，宣称 适合饮品调制、礼赠、运动等场景，产品在恒顺味道商城官方小程序售价为480ml*6瓶/42元。 ...

北京商报讯（记者 宋亦桐）1月28日，据中央纪委国家监委网站消息，据中央纪委国家监委驻中国工商 银行（601398）纪检监察组、河北省纪委监委消息：中国工商银行云南省分行原党委书记、行长郭伟涉 嫌严重违纪违法，目前正接受中央纪委国家监委驻中国工商银行纪检监察组纪律审查和河北省监察委员 会监察调查。 ...

Core Viewpoint - The company 麦趣尔 is facing significant financial difficulties, including a debt crisis and ongoing legal issues, which have led to substantial losses and a declining revenue trend over recent years [3][4][5][6]. Group 1: Debt Crisis and Legal Issues - 麦趣尔 has an outstanding debt of 5.95 million yuan related to machinery purchases, with only 30% of the payment made [3]. - The company has been involved in 84 legal cases, with 27 instances where it was designated as an executed party, amounting to 221 million yuan in total claims [4]. - Despite the bankruptcy application from creditors, the company has not received any court ruling on the matter and is actively contesting the claims [3][4]. Group 2: Financial Performance - 麦趣尔 has reported declining revenues over the years, with revenues of approximately 989 million yuan in 2022, dropping to 463 million yuan in the first three quarters of 2025 [6]. - The company has experienced net losses of around 351 million yuan in 2022, 97.1 million yuan in 2023, and 23 million yuan in 2024, continuing into 2025 with a loss of 33 million yuan [6]. - As of mid-2025, 麦趣尔's total assets were approximately 1.075 billion yuan, with total liabilities of about 855 million yuan, resulting in a debt ratio of 79.55%, which increased to 83.04% by the end of the third quarter [7]. Group 3: Regulatory and Market Position - 麦趣尔 has faced regulatory penalties due to food safety violations, including a fine of 73.15 million yuan, which significantly impacted its profitability for 2020 and 2021 [5]. - The company’s stock is not currently at risk of being delisted despite ongoing losses, as it meets certain revenue thresholds and maintains positive net assets [7].

北京商报讯（记者 董晗萱）1月28日，据人民银行北京市分行非银行支付机构重大事项变更许可信息， 同意易智付科技（北京）有限公司变更公司名称为北京首信易支付科技有限公司。此外，同意北京恒信 通电信服务有限公司变更公司名称为北京恒信通支付服务有限公司。 ...

公告显示，*ST观典预计2025年年度实现营业收入为1.23亿元左右，扣除与主营业务无关的业务收入和 不具备商业实质的收入后的营业收入为1.23亿元左右。公司股票于2025年4月30日起被实施退市风险警 示。由于公司2025年度审计工作尚未结束，因此预计的扣除与主营业务无关的业务收入和不具备商业实 质的收入后的营业收入存在不确定性，仍存在扣除与主营业务无关的业务收入和不具备商业实质的收入 后的营业收入低于1亿元且利润总额、净利润（扣除非经常性损益前后孰低）为负而触及财务类退市标 准的风险。除此以外，若公司出现《上市规则》第12.4.10及12.4.14条规定的情形，公司股票可能被上交 所终止上市。 *ST观典表示，期末公司对长期资产进行减值测试，受宏观经济环境影响，房屋建筑物等长期资产出现 减值。 北京商报讯（记者 马换换 李佳雪）1月28日晚间，*ST观典（688287）披露公告称，公司预计2025年年 度实现利润总额-1.89亿元左右；预计2025年年度实现归属净利润为-1.85亿元左右；预计2025年年度实 现扣非后归属净利润-1.78亿元左右。 ...